Correction: Should Remdesivir Be Used for the Treatment of Patients With COVID-19?
Authors: Amir Qaseem, MD, PhD, MHA, Jennifer Yost, PhD, RN, Itziar Etxeandia-Ikobaltzeta, PharmD, PhD, George M. Abraham, MD, MPH, Janet A. Jokela, MD, MPH
Journal: Annals of Internal Medicine (2021)

Corrections16 March 2021Correction: Should Remdesivir Be Used for the Treatment of Patients With COVID-19?FREEThis correction concerns the following article:Clinical GuidelinesMay 2021Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)FREEAmir Qaseem, MD, PhD, MHA, Jennifer Yost, PhD, RN, Itziar Etxeandia-Ikobaltzeta, PharmD, PhD, George M. Abraham, MD, MPH, Janet A. Jokela, MD, MPHAmir Qaseem, MD, PhD, MHAAmerican College of Physicians, Philadelphia, Pennsylvania (A.Q., I.E.), Jennifer Yost, PhD, RNAmerican College of Physicians, Philadelphia, and Villanova University, Villanova, Pennsylvania (J.Y.), Itziar Etxeandia-Ikobaltzeta, PharmD, PhDAmerican College of Physicians, Philadelphia, Pennsylvania (A.Q., I.E.), George M. Abraham, MD, MPHUniversity of Massachusetts Medical School and Saint Vincent Hospital, Worcester, Massachusetts (G.M.A.), Janet A. Jokela, MD, MPHUniversity of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois (J.A.J.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L21-0138 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The supporting systematic review (1) for version 2 of the American College of Physicians' rapid, living practice points on effectiveness of a 10-day course of remdesivir compared with placebo or standard care (SC) in hospitalized patients with COVID-19 contained an error: The magnitude of the mortality reduction among patients receiving supplemental oxygen but not needing ventilation should have been described as “small” rather than “modest.” This has now been corrected in the practice points (2) under the rationale for Practice Point 1 and in Table 2. The correction does not affect the overall conclusions.Footnotes also were added to the Appendix Table to clarify that the certainty of evidence was not assessed for the subgroup analyses reported under mortality (10-day course vs. placebo or SC; also corrected in Table 2), serious adverse events (5-day vs. 10-day course), time to recovery (10-day course vs. placebo or SC), time to clinical improvement (10-day course vs. placebo or SC), and mechanical ventilation or extracorporeal membrane oxygenation (5-day vs. 10-day course).The online version has been corrected.References1. Kaka AS, MacDonald R, Greer N, et al. Major update: remdesivir for adults with COVID-19. A living systematic review and meta-analysis for the American College of Physicians practice points. Ann Intern Med. 9 February 2021 [Epub ahead of print]. [PMID: 33560863] doi:10.7326/M20-8148 LinkGoogle Scholar2. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, et al. Should remdesivir be used for the treatment of patients with COVID-19? Rapid, living practice points from the American College of Physicians (version 2). Ann Intern Med. 9 February 2021 [Epub ahead of print]. [PMID: 33560862] doi:10.7326/M20-8101 LinkGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationThis article was published at Annals.org on 16 March 2021. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoShould Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2) Amir Qaseem , Jennifer Yost , Itziar Etxeandia-Ikobaltzeta , George M. Abraham , Janet A. Jokela , Mary Ann Forciea , Matthew C. Miller , and Linda L. Humphrey , for the Scientific Medical Policy Committee of the American College of Physicians* Metrics May 2021Volume 174, Issue 5Page: 735-736 ePublished: 16 March 2021 Issue Published: May 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...